Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:13 PM
Ignite Modification Date:
2025-12-24 @ 9:13 PM
NCT ID:
NCT00104104
Eligibility Criteria:
Inclusion Criteria:
* Patients 18 years of age or older
* Confirmed diagnosis of Multiple Myeloma
* Stable renal function defined as two serum creatinine determinations of \< 3 mg/dL
* Calculated creatinine clearance of greater than or equal to 30 mL/min
* ECOG Performance Status of 0 or 1
* Life expectancy of greater than or equal to 9 months
* If the patient is of child-bearing potential, a negative pregnancy test is required at screening, while postmenopausal women must be amenorrheic for at least 12 months to be considered of non-childbearing potential.
* Ability to comply with trial requirements and give informed consent.
Exclusion Criteria:
* IV Bisphosphonate therapy for more than 3 years.
* Patients with a diagnosis of amyloidosis.
* Known hypersensitivity to zoledronic acid or other bisphosphonates
* Pregnant patients or lactating patients.
* Women of childbearing potential not on a medically recognized form of contraception
* Patients with uncontrolled cardiovascular disease, hypertension, and Type 2 diabetes mellitus.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00104104
Study Brief:
Protocol Section:
NCT00104104